$1.3 Billion is the total value of Eversept Partners, LP's 86 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MNKD | Exit | MANNKIND CORPcall | $0 | – | -50,000 | -100.0% | -0.01% | – |
| FSTX | Exit | F-STAR THERAPEUTICS INC | $0 | – | -49,933 | -100.0% | -0.02% | – |
| JYNT | Exit | JOINT CORPput | $0 | – | -5,500 | -100.0% | -0.02% | – |
| BKD | Exit | BROOKDALE SR LIVING INC | $0 | – | -79,146 | -100.0% | -0.03% | – |
| LOGC | Exit | LOGICBIO THERAPEUTICS INC | $0 | – | -291,101 | -100.0% | -0.04% | – |
| VCRA | Exit | VOCERA COMMUNICATIONS INC | $0 | – | -14,970 | -100.0% | -0.06% | – |
| MYO | Exit | MYOMO INC | $0 | – | -150,000 | -100.0% | -0.07% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DELcall | $0 | – | -7,600 | -100.0% | -0.10% | – |
| ESTA | Exit | ESTABLISHMENT LABS HLDGS INC | $0 | – | -25,137 | -100.0% | -0.11% | – |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -38,672 | -100.0% | -0.12% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCcall | $0 | – | -84,600 | -100.0% | -0.13% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -14,840 | -100.0% | -0.14% | – |
| GRTS | Exit | GRITSTONE BIO INC | $0 | – | -170,125 | -100.0% | -0.14% | – |
| CVAC | Exit | CUREVAC N V | $0 | – | -85,017 | -100.0% | -0.19% | – |
| LXRX | Exit | LEXICON PHARMACEUTICALS INC | $0 | – | -797,694 | -100.0% | -0.20% | – |
| MRVI | Exit | MARAVAI LIFESCIENCES HLDGS I | $0 | – | -87,795 | -100.0% | -0.24% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -201,384 | -100.0% | -0.29% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -66,074 | -100.0% | -0.34% | – |
| SIBN | Exit | SI-BONE INC | $0 | – | -258,094 | -100.0% | -0.37% | – |
| CERN | Exit | CERNER CORP | $0 | – | -77,543 | -100.0% | -0.46% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB Lcall | $0 | – | -70,000 | -100.0% | -0.48% | – |
| PODD | Exit | INSULET CORP | $0 | – | -30,172 | -100.0% | -0.51% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -550,966 | -100.0% | -0.57% | – |
| NTRA | Exit | NATERA INC | $0 | – | -102,071 | -100.0% | -0.61% | – |
| MGLN | Exit | MAGELLAN HEALTH INC | $0 | – | -104,700 | -100.0% | -0.64% | – |
| ARKK | Exit | ARK ETF TRinnovation etf | $0 | – | -119,118 | -100.0% | -0.72% | – |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INC | $0 | – | -231,787 | -100.0% | -0.78% | – |
| HUM | Exit | HUMANA INC | $0 | – | -27,382 | -100.0% | -0.81% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -113,800 | -100.0% | -0.81% | – |
| ARKG | Exit | ARK ETF TRcall | $0 | – | -243,800 | -100.0% | -0.95% | – |
| CYH | Exit | COMMUNITY HEALTH SYS INC NEWcall | $0 | – | -1,277,200 | -100.0% | -1.09% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INCcall | $0 | – | -94,100 | -100.0% | -1.32% | – |
| IWM | Exit | ISHARES TRput | $0 | – | -125,000 | -100.0% | -1.78% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.